Phase 1 trial shows MBX 1416 is safe and well-tolerated, advancing to Phase 2 for PBH in late 2025. MBX Biosciences announced positive Phase 1 clinical trial results for its investigational drug MBX ...
The design of a closed-loop switch-mode power supply creates a path between the variable a designer wants to monitor and the control pin of the designer's converter. This control pin can be the peak ...
Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback